Press Release Hub logo
  • Submit a Release
  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Instem Announces Provantis® 12: A Powerful Step Forward in Preclinical Study Management

Contributed by: Business Wire

Logo

Business Wire logo

Tags

Software
Research
Professional Services
Data Management
Technology
Health Technology
Health Insurance
Data Analytics
Clinical Trials
Science
Biotechnology
Health
Provantis 12

More Like This

Business Wire logo

Driving Pathology Forward: Instem Strengthens Provantis® with Continued Investment and Innovation

Business Wire logo

Instem Introduces Cloud-Hosted Non-GLP Pathology Module for Provantis

Business Wire logo

Instem Strengthens Commitment to End-to-End Preclinical Platform Amid Regulatory Evolution

Business Wire logo

Instem Now Part of ARCHIMED to Further Accelerate Growth and Impact

PR Newswire associated0

More Than 200 Companies Advance Trial Management with Veeva CTMS

PR Newswire associated0

Veeva Announces Research Site Clinical Trial Management System

Business Wire logo

Veristat Acquires Biometrics-focused Instat Clinical Research

Business Wire logo

Protembis Announces Completion of € 30 Million Series B Financing Round and the Addition of Keith D Dawkins MD to the Board of Directors

Pages

  • Home
  • All
  • ESG
  • Health
  • Technology
  • Finance
  • Contributors

Press Release Hub

  • Our Services
  • Submit a Release

Websites

  • PA Media Group
  • PA Mediapoint
  • Distribution Packages

© PA Media Group. 2025

Terms of Use

Privacy Policy

Contact Us